Primary |
Drug Use For Unknown Indication |
20.2% |
Product Used For Unknown Indication |
14.1% |
Maternal Therapy To Enhance Foetal Lung Maturity |
7.6% |
Bronchitis |
5.3% |
Pyrexia |
5.3% |
Asthma |
4.6% |
Pain |
4.6% |
Osteoarthritis |
4.2% |
Neuropathy Peripheral |
3.8% |
Sinusitis |
3.8% |
Microscopic Polyangiitis |
3.4% |
Rash |
3.0% |
Tocolysis |
3.0% |
Breast Cancer |
2.7% |
Dermatitis Atopic |
2.7% |
Prophylaxis |
2.7% |
Anaplastic Astrocytoma |
2.3% |
Diabetes Mellitus |
2.3% |
Dyspnoea |
2.3% |
Rhinorrhoea |
2.3% |
|
Exposure During Pregnancy |
18.6% |
Pain |
9.3% |
Vomiting |
9.3% |
Pain In Extremity |
5.8% |
Premature Baby |
5.8% |
Rash Maculo-papular |
5.8% |
Stevens-johnson Syndrome |
5.8% |
Pyrexia |
4.7% |
Maternal Exposure During Pregnancy |
3.5% |
Pharmaceutical Product Complaint |
3.5% |
Pneumonia Aspiration |
3.5% |
Respiratory Arrest |
3.5% |
Vascular Purpura |
3.5% |
Weight Increased |
3.5% |
Angioedema |
2.3% |
Coma |
2.3% |
Condition Aggravated |
2.3% |
Drug Effect Decreased |
2.3% |
Drug Eruption |
2.3% |
Drug Exposure During Pregnancy |
2.3% |
|
Secondary |
Product Used For Unknown Indication |
28.2% |
Drug Use For Unknown Indication |
13.8% |
Cataract Operation |
8.5% |
Prophylaxis |
5.0% |
Foetal Exposure During Pregnancy |
4.1% |
Asthma |
3.9% |
Maternal Exposure Timing Unspecified |
3.7% |
Hiv Infection |
3.6% |
Pain |
3.3% |
Preoperative Care |
3.0% |
Eye Irrigation |
2.5% |
Bipolar Disorder |
2.4% |
Otitis Media Acute |
2.4% |
Neuropathy Peripheral |
2.3% |
Postoperative Care |
2.3% |
Pustular Psoriasis |
2.3% |
Diabetes Mellitus |
2.2% |
Insomnia |
2.2% |
Interstitial Lung Disease |
2.2% |
Testicular Germ Cell Tumour Mixed Stage Iii |
2.2% |
|
Premature Baby |
17.7% |
Toxic Anterior Segment Syndrome |
12.7% |
Foetal Exposure During Pregnancy |
6.3% |
Osteonecrosis |
5.1% |
Premature Delivery |
5.1% |
Solitary Kidney |
5.1% |
Respiratory Arrest |
4.4% |
Stevens-johnson Syndrome |
4.4% |
Vomiting |
4.4% |
Caesarean Section |
3.8% |
Pyrexia |
3.8% |
Exposure During Pregnancy |
3.2% |
Pneumonia |
3.2% |
Premature Labour |
3.2% |
Rash |
3.2% |
Septic Shock |
3.2% |
Tendon Rupture |
3.2% |
White Blood Cell Count Decreased |
3.2% |
Cerebral Haemorrhage |
2.5% |
Death |
2.5% |
|
Concomitant |
Product Used For Unknown Indication |
21.5% |
Prophylaxis |
13.3% |
Drug Use For Unknown Indication |
13.3% |
Rheumatoid Arthritis |
7.7% |
Multiple Myeloma |
5.5% |
Asthma |
4.6% |
Hypertension |
4.2% |
Psoriasis |
3.5% |
Breast Cancer |
3.0% |
Constipation |
3.0% |
Pain |
2.7% |
Cancer Pain |
2.5% |
Ovarian Cancer Recurrent |
2.3% |
Insomnia |
2.2% |
Depression |
2.0% |
Behcet's Syndrome |
2.0% |
Hepatitis C |
1.8% |
Crohn's Disease |
1.7% |
Renal Cell Carcinoma |
1.6% |
Diabetes Mellitus |
1.5% |
|
Premature Baby |
12.8% |
Pyrexia |
6.8% |
Premature Labour |
6.7% |
Vomiting |
6.7% |
Interstitial Lung Disease |
6.5% |
Platelet Count Decreased |
5.7% |
Rash |
5.7% |
Thrombocytopenia |
5.0% |
Weight Increased |
5.0% |
Pneumonia |
4.8% |
White Blood Cell Count Decreased |
4.8% |
Weight Decreased |
4.6% |
Small For Dates Baby |
4.1% |
Pain |
3.8% |
Toxic Epidermal Necrolysis |
3.4% |
Renal Failure |
3.1% |
Drug Exposure During Pregnancy |
2.7% |
Stevens-johnson Syndrome |
2.7% |
Respiratory Failure |
2.6% |
Somnolence |
2.6% |
|
Interacting |
Hiv Infection |
19.4% |
Cystoid Macular Oedema |
9.7% |
Cytomegalovirus Chorioretinitis |
9.7% |
Product Used For Unknown Indication |
9.7% |
Uveitis |
9.7% |
Vertigo |
9.7% |
Antiretroviral Therapy |
4.8% |
Pruritus |
4.8% |
Skin Ulcer |
4.8% |
Asymptomatic Hiv Infection |
3.2% |
Back Pain |
3.2% |
Macular Oedema |
3.2% |
Arrhythmia |
1.6% |
Ear Infection |
1.6% |
Epilepsy |
1.6% |
Mitral Valve Replacement |
1.6% |
Sleep Disorder |
1.6% |
|
Weight Increased |
33.3% |
Adrenal Suppression |
11.1% |
Blood Cholesterol Increased |
11.1% |
Constipation |
11.1% |
Cushing's Syndrome |
11.1% |
Infection |
11.1% |
Prothrombin Time Shortened |
11.1% |
|